Ebunat 0.5® Eribulin Injection

Ebunat contains eribulin mesylate, a chemotherapy medicine used to treat locally advanced or metastatic breast cancer that has progressed after previous chemotherapy. It is also used for certain cases of unresectable or metastatic liposarcoma following prior treatment.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.